Treatment Protocol for Abnormal Arterial Blood Gas (ABG) Results
The treatment of abnormal ABG results depends on the specific abnormality identified—respiratory acidosis, respiratory alkalosis, metabolic acidosis, or metabolic alkalosis—with immediate intervention focused on correcting hypoxemia first (as prevention of tissue hypoxia supersedes CO2 retention concerns), followed by addressing the underlying acid-base disturbance through targeted oxygen therapy, ventilatory support, or metabolic correction. 1
Initial Assessment and Identification
When ABG results are abnormal, systematically identify the primary disturbance:
- Respiratory acidosis: pH <7.35 with PaCO2 >45 mmHg (>6.0 kPa) 1
- Respiratory alkalosis: pH >7.45 with PaCO2 <35 mmHg 1
- Metabolic acidosis: pH <7.35 with normal or low PaCO2 and low bicarbonate 1, 2
- Metabolic alkalosis: pH >7.45 with elevated bicarbonate 1
Treatment of Hypoxemia (Regardless of Acid-Base Status)
Oxygen therapy should be initiated immediately for any patient with hypoxemia, as preventing tissue hypoxia takes priority over concerns about CO2 retention. 3
Oxygen Titration Protocol
- For patients WITHOUT known CO2 retention: Target SpO2 94-98% 1
- For patients WITH COPD or risk of hypercapnic respiratory failure: 1
Monitoring During Oxygen Therapy
- If PaCO2 rises >1 kPa (7.5 mmHg) during oxygen therapy, the patient has clinically unstable disease requiring further medical optimization 1
- If respiratory acidosis develops (pH <7.35 and PCO2 >6.0 kPa), seek immediate senior review and consider ventilatory support 2
Treatment of Respiratory Acidosis
For severe respiratory acidosis with pH <7.35 and rising PaCO2, non-invasive ventilation (NIV) or mechanical ventilation should be considered rather than simply reducing oxygen therapy. 1
Stepwise Approach
- Optimize oxygen delivery while monitoring for worsening hypercapnia 1
- Consider NIV for acute hypercapnic respiratory failure—obtain ABG before and after starting NIV 2
- For persistent respiratory acidosis despite optimization, consider nocturnal ventilatory support 1
- Repeat ABG at 30-60 minute intervals if target saturation not achieved or respiratory deterioration occurs 2
Common Pitfall
Do not reduce oxygen therapy in response to rising CO2 if the patient remains hypoxemic—this can cause dangerous rebound hypoxemia. Instead, add ventilatory support. 2
Treatment of Metabolic Acidosis
For Severe Metabolic Acidosis (Cardiac Arrest)
In cardiac arrest, administer sodium bicarbonate 44.6-100 mEq (one to two 50 mL vials) IV rapidly initially, then continue at 50 mL every 5-10 minutes as indicated by arterial pH and blood gas monitoring. 4
For Less Urgent Metabolic Acidosis
Administer 2-5 mEq/kg body weight of sodium bicarbonate over 4-8 hours, with stepwise titration based on repeated ABG measurements rather than attempting full correction in the first 24 hours. 4
- Target total CO2 content of approximately 20 mEq/L at end of first day (attempting full correction risks overshoot alkalosis) 4
- Monitor with blood gases, plasma osmolarity, arterial lactate, and hemodynamics 4
Timing of Repeat ABG in Metabolic Acidosis
- Initial repeat: Within 60 minutes of starting oxygen therapy 2
- During active treatment: Every 2-4 hours for diabetic ketoacidosis (venous pH adequate after initial arterial sample) 2
- After interventions: Within 30-60 minutes if respiratory deterioration occurs 2
- Continue monitoring until: pH normalizes, anion gap <12 mEq/L, and bicarbonate ≥18 mEq/L 2
Special Consideration for DKA
After initial arterial ABG, venous pH is adequate for monitoring (typically 0.03 units lower than arterial pH)—repeat arterial blood gases are generally unnecessary. 2
Treatment of Respiratory Alkalosis
- Address underlying cause (anxiety, pain, sepsis, mechanical overventilation) 1
- If mechanically ventilated, reduce minute ventilation by decreasing respiratory rate or tidal volume
- Monitor with repeat ABG after ventilator adjustments
Critical Monitoring Points
When to Repeat ABG
- Within 60 minutes of starting oxygen therapy in any patient with acid-base disturbance 1, 2
- Within 60 minutes after any change in inspired oxygen concentration 1, 2
- Every 30-60 minutes during active titration in unstable patients 2
- Before and after starting NIV 2
- After each titration of oxygen flow rate in patients with baseline hypercapnia 1, 2
Common Pitfalls to Avoid
- Do not rely on pulse oximetry alone: Normal SpO2 does not rule out significant acid-base disturbances or hypercapnia 1, 2
- Do not withhold oxygen due to fear of CO2 retention—add ventilatory support instead 3
- Do not attempt full correction of metabolic acidosis in first 24 hours (risks overshoot alkalosis) 4
- Do not use arterial samples when venous pH is adequate (e.g., DKA monitoring after initial assessment) 2
Special Populations
COPD Patients
- Start oxygen at 1 L/min and titrate cautiously 1
- Target SpO2 88-92% rather than 94-98% 1
- Check ABG when starting oxygen therapy, especially if known CO2 retention 1
- After 4 weeks of medical optimization, reassess patients who developed respiratory acidosis 2